Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM.

Nordestgaard BG, Langlois MR, Langsted A, Chapman MJ, Aakre KM, Baum H, Borén J, Bruckert E, Catapano A, Cobbaert C, Collinson P, Descamps OS, Duff CJ, von Eckardstein A, Hammerer-Lercher A, Kamstrup PR, Kolovou G, Kronenberg F, Mora S, Pulkki K, Remaley AT, Rifai N, Ros E, Stankovic S, Stavljenic-Rukavina A, Sypniewska G, Watts GF, Wiklund O, Laitinen P; European Atherosclerosis Society (EAS) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Joint Consensus Initiative.

Atherosclerosis. 2020 Jan 9. pii: S0021-9150(19)31623-5. doi: 10.1016/j.atherosclerosis.2019.12.005. [Epub ahead of print] Review.

PMID:
31928713
2.

Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM.

Langlois MR, Nordestgaard BG, Langsted A, Chapman MJ, Aakre KM, Baum H, Borén J, Bruckert E, Catapano A, Cobbaert C, Collinson P, Descamps OS, Duff CJ, von Eckardstein A, Hammerer-Lercher A, Kamstrup PR, Kolovou G, Kronenberg F, Mora S, Pulkki K, Remaley AT, Rifai N, Ros E, Stankovic S, Stavljenic-Rukavina A, Sypniewska G, Watts GF, Wiklund O, Laitinen P; European Atherosclerosis Society (EAS) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Joint Consensus Initiative.

Clin Chem Lab Med. 2019 Dec 19. pii: /j/cclm.ahead-of-print/cclm-2019-1253/cclm-2019-1253.xml. doi: 10.1515/cclm-2019-1253. [Epub ahead of print]

PMID:
31855562
3.

How Well Do Laboratories Adhere to Recommended Clinical Guidelines for the Management of Myocardial Infarction: The CARdiac MArker Guidelines Uptake in Europe Study (CARMAGUE).

Collinson P, Hammerer-Lercher A, Suvisaari J, Apple FS, Christenson RH, Pulkki K, van Dieijen-Visser MP, Duff CJ, Baum H, Stavljenic-Rukavina A, Aakre KM, Langlois MR, Stankovic S, Laitinen P; Working Group for Cardiac Markers, European Federation of Clinical Chemistry and Laboratory Medicine.

Clin Chem. 2016 Sep;62(9):1264-71. doi: 10.1373/clinchem.2016.259515. Epub 2016 Jul 26.

4.

Do laboratories follow heart failure recommendations and guidelines and did we improve? The CARdiac MArker Guideline Uptake in Europe (CARMAGUE).

Hammerer-Lercher A, Collinson P, van Dieijen-Visser MP, Pulkki K, Suvisaari J, Ravkilde J, Stavljenic-Rukavina A, Baum H, Laitinen P.

Clin Chem Lab Med. 2013 Jun;51(6):1301-6. doi: 10.1515/cclm-2012-0510.

PMID:
23334056
5.

Evidence-based laboratory medicine: how well do laboratories follow recommendations and guidelines? The Cardiac Marker Guideline Uptake in Europe (CARMAGUE) study.

Collinson PO, van Dieijen-Visser MP, Pulkki K, Hammerer-Lercher A, Suvisaari J, Ravkilde J, Stavljenic-Rukavina A, Baum H, Laitinen P.

Clin Chem. 2012 Jan;58(1):305-6. doi: 10.1373/clinchem.2011.171439. Epub 2011 Sep 27. No abstract available.

6.

Dioxins and human toxicity.

Marinković N, Pašalić D, Ferenčak G, Gršković B, Stavljenić Rukavina A.

Arh Hig Rada Toksikol. 2010 Dec;61(4):445-53. doi: 10.2478/10004-1254-61-2010-2024. Review.

PMID:
21183436
7.

5. Hereditary Kidney Disorders.

Stavljenić-Rukavina A.

EJIFCC. 2009 Apr 20;20(1):33-40. eCollection 2009 Apr. No abstract available.

8.

[Quality in health care].

Stavljenić-Rukavina A.

Lijec Vjesn. 2008 Nov-Dec;130(11-12):306-10. Review. Croatian.

PMID:
19146191
9.

A pilot survey of the use and implementation of cardiac markers in acute coronary syndrome and heart failure across Europe. The CARdiac MArker Guideline Uptake in Europe (CARMAGUE) study.

Pulkki K, Suvisaari J, Collinson P, Ravkilde J, Stavljenic-Rukavina A, Hammerer-Lercher A, Baum H, van Dieijen-Visser MP, Laitinen P.

Clin Chem Lab Med. 2009;47(2):227-34. doi: 10.1515/CCLM.2009.044.

PMID:
19099527
10.

[Prevalence of ultraextensive drug metabolizers in Croatian population--long-PCR based detection of amplified CYP2D6 gene].

Bozina N, Tramisak I, Granić P, Puljević D, Stavljenić-Rukavina A.

Lijec Vjesn. 2002 Mar-Apr;124(3-4):63-6. Croatian.

PMID:
18958918
11.

Association of angiotensin-converting enzyme insertion-deletion polymorphism with preeclampsia.

Misković B, Sertić J, Stavljenić-Rukavina A, Stipoljev F.

Coll Antropol. 2008 Jun;32(2):339-43.

PMID:
18756878
12.

C-reactive protein gene polymorphisms affect plasma CRP and homocysteine concentrations in subjects with and without angiographically confirmed coronary artery disease.

Pasalić D, Marinković N, Grsković B, Ferencak G, Bernat R, Stavljenić-Rukavina A.

Mol Biol Rep. 2009 Apr;36(4):775-80. doi: 10.1007/s11033-008-9244-1. Epub 2008 Apr 10.

PMID:
18401567
13.

1. Prenatal Diagnosis of Chromosomal Disorders - Molecular Aspects.

Stavljenić-Rukavina A.

EJIFCC. 2008 Apr 3;19(1):2-6. eCollection 2008 Apr. No abstract available.

14.

[Influence of gene polymorphisms in adhesion molecules and inflammation mediators as risk factors for coronary heart disease and myocardial infarction--an overview].

Grsković B, Pasalić D, Ferencak G, Stavljenić-Rukavina A.

Acta Med Croatica. 2008 Feb;62(1):41-52. Review. Croatian.

PMID:
18365499
15.

How well do laboratories follow guidelines on cardiac markers? The cardiac marker guideline uptake in Europe study.

Collinson P, Pulkki K, Suvisaari J, Ravkilde J, Stavljenic-Rukavina A, Hammerer-Lercher A, Baum H, van Dieijen-Visser MP, Laitinen PH.

Clin Chem. 2008 Feb;54(2):448-9. doi: 10.1373/clinchem.2007.097501. No abstract available.

16.

Impact of FXIII-A Val34Leu polymorphism on coronary artery disease in Croatian patients.

Bronić A, Ferencak G, Zadro R, Stavljenić-Rukavina A, Bernat R.

Mol Biol Rep. 2009 Jan;36(1):1-5. Epub 2007 Sep 27.

PMID:
17899444
17.

[Lipoprotein lipase--physiological and pathophysiological roles of this gene variant in Croatian population].

Pasalić D, Stavljenić-Rukavina A.

Lijec Vjesn. 2007 Jan-Feb;129(1-2):32-8. Review. Croatian.

PMID:
17489516
18.

[The frequencies of apolipoprotein E genotypes in health and disease in the Croatian population--an overview of expectations and real results].

Pasalić D, Ferencak G, Grsković B, Stavljenic-Rukavina A.

Acta Med Croatica. 2006 Dec;60(5):403-10. Croatian.

PMID:
17217095
19.

Association of two genetic variations of lipoprotein lipase, S447X and Hind III, with coronary artery disease and hypertriglyceridemia.

Pasalić D, Ferencak G, Grsković B, Sesto M, Stavljenić-Rukavina A.

Coll Antropol. 2006 Sep;30(3):549-54.

PMID:
17058522
20.

Proinflammatory factors in saliva as possible markers for periodontal disease.

Aurer A, Jorgić-Srdjak K, Plancak D, Stavljenić-Rukavina A, Aurer-Kozelj J.

Coll Antropol. 2005 Dec;29(2):435-9.

PMID:
16417140
21.

[Development of laboratory information system--quality standards].

Srenger V, Stavljenić-Rukavina A, Cvorisćec D, Brkljacić V, Rogić D, Juricić L.

Acta Med Croatica. 2005;59(3):233-9. Croatian.

PMID:
16095197
22.

Evaluation of the Konelab 20XT clinical chemistry analyzer.

Stojanović N, Rogić D, Stavljenić-Rukavina A.

Clin Chem Lab Med. 2005;43(6):646-53.

PMID:
16006262
23.

[Markers of periodontal destruction in saliva of periodontitis patients].

Aurer A, Stavljenić-Rukavina A, Aurer-Kozelj J.

Acta Med Croatica. 2005;59(2):117-22. Croatian.

PMID:
15909885
24.

[Gaucher disease: diagnosis and treatment].

Fumić K, Stavljenić-Rukavina A, Mrsić M, Potocki K.

Acta Med Croatica. 2004;58(5):353-8. Review. Croatian.

PMID:
15756799
25.

Apolipoprotein H (apoH)-dependent autoantibodies and apoH protein polymorphism in selected patients showing lupus anticoagulant activity.

Vogrinc Z, Trbojević-Cepe M, Coen D, Vitale K, Stavljenić-Rukavina A.

Clin Chem Lab Med. 2005;43(1):17-21.

PMID:
15653437
26.

ApoE genotyping and response to galanthamine in Alzheimer's disease--a real life retrospective study.

Babić T, Mahović Lakusić D, Sertić J, Petrovecki M, Stavljenić-Rukavina A.

Coll Antropol. 2004 Jun;28(1):199-204.

PMID:
15636076
27.

Molecular Mechanisms in Alzheimer's Disease.

Stavljenic-Rukavina A.

EJIFCC. 2004 Aug 31;15(3):100-103. eCollection 2004 Aug. No abstract available.

28.

Missense mutation W86R in exon 3 of the lipoprotein lipase gene in a boy with chylomicronemia.

Pasalić D, Jurcić Z, Stipancić G, Ferencak G, Leren TP, Djurovic S, Stavljenić-Rukavina A.

Clin Chim Acta. 2004 May;343(1-2):179-84.

PMID:
15115692
29.

Management of Gaucher disease in a post-communist transitional health care system: Croatian experience.

Mrsić M, Stavljenić-Rukavina A, Fumić K, Labar B, Bogdanić V, Potocki K, Kardum-Skelin I, Rovers D.

Croat Med J. 2003 Oct;44(5):606-9.

30.

Products of advanced glycation in patients with type 2 diabetes and vascular disease.

Turk Z, Sesto M, Skodlar J, Ferencak G, Pokupec R, Turk N, Stavljenić-Rukavina A.

Ann Clin Biochem. 2003 Sep;40(Pt 5):552-9.

PMID:
14503994
31.

Genetic polymorphisms of cytochromes P450: CYP2C9, CYP2C19, and CYP2D6 in Croatian population.

Bozina N, Granić P, Lalić Z, Tramisak I, Lovrić M, Stavljenić-Rukavina A.

Croat Med J. 2003 Aug;44(4):425-8.

32.

Genetics of Cardiovascular Disease.

Stavljenic-Rukavina A.

EJIFCC. 2003 Jul 3;14(2):53-58. eCollection 2003 Jul. No abstract available.

33.

The effect of dichlorvos treatment on butyrylcholinesterase activity and lipid metabolism in rats.

Lucić A, Bradamante V, Radić B, Peraica M, Domijan AM, Fuchs R, Stavljenić-Rukavina A.

Arh Hig Rada Toksikol. 2002 Dec;53(4):275-81.

PMID:
12828128
34.

Acute promyelocytic leukemia M3: cytomorphologic, immunophenotypic, cytogenetic, and molecular variants.

Sucić M, Zadro R, Burazer B, Labar B, Nemet D, Mrsić M, Aurer I, Mrsić S, Hitrec V, Boban D, Marković-Glamocak M, Batinić D, Uzarević B, Stavljenić-Rukavina A.

J Hematother Stem Cell Res. 2002 Dec;11(6):941-50.

PMID:
12590709
35.

[Rational utilization of laboratory diagnosis].

Rogić D, Cvorisćec D, Stavljenić-Rukavina A.

Lijec Vjesn. 2002 May;124(5):161-4. Croatian.

PMID:
12152418
36.

Soluble LDL-immune complexes in type 2 diabetes and vascular disease.

Turk Z, Sesto M, Skodlar J, Ferencak G, Turk N, Stavljenić-Rukavina A.

Horm Metab Res. 2002 Apr;34(4):196-201.

PMID:
11987029
37.

Lipoprotein lipase gene polymorphism and lipid profile in patients with hypertriglyceridemia.

Pasalić D, Sertić J, Kunović B, Milicević Z, Pasić A, Zrinski-Topić R, Ferencak G, Stavljenić-Rukavina A.

Croat Med J. 2001 Oct;42(5):517-22.

38.

Lack of association between burning mouth syndrome and hematinic deficiencies.

Vucicevic-Boras V, Topic B, Cekic-Arambasin A, Zadro R, Stavljenic-Rukavina A.

Eur J Med Res. 2001 Sep 28;6(9):409-12.

PMID:
11591532
39.

Clinical laboratory in the third millennium.

Rogić D, Stavljenić-Rukavina A.

Acta Med Croatica. 2001;55(2):59-60. No abstract available.

PMID:
11505628
40.

Prevalence and association of the factor V Leiden and prothrombin G20210A in healthy subjects and patients with venous thromboembolism.

Coen D, Zadro R, Honović L, Banfić L, Stavljenić Rukavina A.

Croat Med J. 2001 Aug;42(4):488-92.

41.

Genetic markers of male infertility: Y chromosome microdeletions and cystic fibrosis transmembrane conductance gene mutations.

Sertić J, Cvitković P, Myers A, Saiki RK, Stavljenić Rukavina A.

Croat Med J. 2001 Aug;42(4):416-20. Review.

42.

A contiguous deletion syndrome of X-linked agammaglobulinemia and sensorineural deafness.

Richter D, Conley ME, Rohrer J, Myers LA, Zahradka K, Kelecić J, Sertić J, Stavljenić-Rukavina A.

Pediatr Allergy Immunol. 2001 Apr;12(2):107-11.

PMID:
11338284
43.

[In situ PCR in the diagnosis of acute leukemia].

Gjadrov Kuvezdić K, Sucić M, Boban D, Marković-Glamocak M, Ries S, Stavljenić-Rukavina A, Labar B.

Lijec Vjesn. 2000 Sep-Oct;122(9-10):222-5. Croatian.

PMID:
11210817
44.

Improvement of early functional atherosclerotic changes in males with hypercholesterolemia after vitamin E supplementation.

Borovnicar A, Keber I, Stavljenić Rukavina A, Yaletel Kragelj L.

Pflugers Arch. 2000;440(5 Suppl):R126-8.

PMID:
11005639
45.

Plasma lipids, lipoprotein Lp(a), apolipoproteins, and hemostatic risk factors distributions in postmenopausal women.

Cubrilo-Turek M, Stavljenić-Rukavina A, Reiner Z, Zrinski R.

Acta Med Croatica. 1999;53(2):61-6.

PMID:
10705622
46.

Double immunoenzymatic APAAP staining for the detection of leukemia-associated immunophenotypes.

Sucić M, Boban D, Marković-Glamocak M, Uzarević B, Zadro R, Petrovecki M, Ries S, Gjadrov K, Golemović M, Stavljenić-Rukavina A, Labar B, Batinić D.

J Hematother Stem Cell Res. 1999 Dec;8(6):635-43.

PMID:
10645771
47.

Effect of different daily doses of gizzerosine on the serum 1,25-dihydroxycholecalciferol concentration in laying hens.

Mrljak V, Grabarević Z, Dzaja P, Barić Rafaj R, Perić J, Artuković B, Bidin Z, Kis S, Stavljenić Rukavina A, Serman V.

Br Poult Sci. 1999 Sep;40(4):523-8.

PMID:
10579412
48.

The usefulness of biochemical bone markers in predicting the response of hormone replacement therapy in perimenopausal cigarette smoking healthy women.

Cubrilo-Turek M, Stavljenić-Rukavina A, Turek S, Kusec V, Duraković Z.

Coll Antropol. 1999 Jun;23(1):195-201.

PMID:
10402723
49.

Inflammatory mediators in saliva of patients with rapidly progressive periodontitis during war stress induced incidence increase.

Aurer A, Aurer-Kozelj J, Stavljenić-Rukavina A, Kalenić S, Ivić-Kardum M, Haban V.

Coll Antropol. 1999 Jun;23(1):117-24.

PMID:
10402713
50.

Apolipoprotein E genotypes and metabolic risk factors for coronary heart disease in middle-aged women.

Cubrilo-Turek M, Stavljenić-Rukavina A, Sertić J, Zrinski R, Turek S, Grgac G, Ljubojević N.

Coll Antropol. 1998 Jun;22(1):149-55.

PMID:
10097431

Supplemental Content

Loading ...
Support Center